Minran Zhou

412 total citations
20 papers, 307 citations indexed

About

Minran Zhou is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Minran Zhou has authored 20 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Hematology and 6 papers in Cancer Research. Recurrent topics in Minran Zhou's work include Chronic Myeloid Leukemia Treatments (7 papers), Cancer-related gene regulation (5 papers) and Acute Myeloid Leukemia Research (4 papers). Minran Zhou is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Cancer-related gene regulation (5 papers) and Acute Myeloid Leukemia Research (4 papers). Minran Zhou collaborates with scholars based in China, Sweden and Norway. Minran Zhou's co-authors include Chunyan Chen, Jihui Jia, Tao Huang, Jiping Zeng, Lixiang Wang, Xiaolu Zhang, Bingnan Li, Yuanyuan Zhang, Yue Fu and Yue Fu and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Minran Zhou

17 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minran Zhou China 10 241 141 77 31 24 20 307
Jingrong Xian China 11 183 0.8× 77 0.5× 79 1.0× 42 1.4× 18 0.8× 13 261
Yuandong Feng China 11 291 1.2× 210 1.5× 59 0.8× 69 2.2× 32 1.3× 23 362
Mary McGrath United States 10 183 0.8× 110 0.8× 53 0.7× 34 1.1× 36 1.5× 19 284
Juliana M. Benito United States 5 125 0.5× 103 0.7× 70 0.9× 50 1.6× 14 0.6× 10 230
Lucie Brožová Czechia 8 137 0.6× 89 0.6× 121 1.6× 59 1.9× 7 0.3× 24 199
Daniela Bräuer-Hartmann Germany 7 231 1.0× 188 1.3× 69 0.9× 14 0.5× 11 0.5× 8 278
Marc Ruíz-Martínez United States 6 242 1.0× 200 1.4× 30 0.4× 24 0.8× 23 1.0× 12 316
Isabel Weinhäuser Brazil 5 110 0.5× 49 0.3× 43 0.6× 49 1.6× 32 1.3× 19 217
Florence Gay Singapore 3 261 1.1× 50 0.4× 32 0.4× 30 1.0× 8 0.3× 4 301

Countries citing papers authored by Minran Zhou

Since Specialization
Citations

This map shows the geographic impact of Minran Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minran Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minran Zhou more than expected).

Fields of papers citing papers by Minran Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minran Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minran Zhou. The network helps show where Minran Zhou may publish in the future.

Co-authorship network of co-authors of Minran Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Minran Zhou. A scholar is included among the top collaborators of Minran Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minran Zhou. Minran Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Minran, et al.. (2024). RNA-Binding Protein Lin28B Promotes Chronic Myeloid Leukemia Blast Crisis by Transcriptionally Upregulating miR-181d. Molecular Cancer Research. 22(10). 932–942.
3.
Fu, Yue, Minran Zhou, Huimin Feng, et al.. (2024). Pan-cancer investigation of RFX family and associated genes identifies RFX8 as a therapeutic target in leukemia. Heliyon. 10(15). e35368–e35368. 2 indexed citations
4.
Liu, Zhenyi, Xiaohan Liu, Qing H. Meng, et al.. (2024). Real-World Results of Brentuximab Vedotin Containing Regimens in CD30 Positive Lymphoma: A Single-Center Retrospective Study. Blood. 144(Supplement 1). 6529–6529.
5.
Guo, Chong, Minran Zhou, Mingshan Sun, et al.. (2023). Development of a novel pyroptosis-related LncRNA signature with multiple significance in acute myeloid leukemia. Frontiers in Genetics. 13. 1029717–1029717. 2 indexed citations
6.
Zhou, Minran, et al.. (2023). Histone demethylase PHF8 facilitates the development of chronic myeloid leukaemia by directly targeting BCR::ABL1. British Journal of Haematology. 202(6). 1178–1191. 3 indexed citations
7.
Yin, Xiaolin, Minran Zhou, Lu Zhang, et al.. (2022). Histone chaperone ASF1A accelerates chronic myeloid leukemia blast crisis by activating Notch signaling. Cell Death and Disease. 13(10). 842–842. 4 indexed citations
8.
Fu, Yue, Zongcheng Yang, Huimin Feng, et al.. (2022). Comprehensive Analysis of a Ferroptosis Pattern and Associated Prognostic Signature in Acute Myeloid Leukemia. Frontiers in Pharmacology. 13. 866325–866325. 13 indexed citations
9.
Zhou, Minran, Xiaolin Yin, Lixin Zheng, et al.. (2021). miR-181d/RBP2/NF-κB p65 Feedback Regulation Promotes Chronic Myeloid Leukemia Blast Crisis. Frontiers in Oncology. 11. 654411–654411. 8 indexed citations
10.
Gao, Zhen, Sai Ma, Fen Liu, et al.. (2021). The New Mitochondrial Uncoupler BAM15 Induces ROS Production for Treatment of Acute Myeloid Leukemia. SSRN Electronic Journal. 1 indexed citations
11.
Fu, Yue, Man Xu, Zongcheng Yang, et al.. (2020). Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia. EBioMedicine. 52. 102664–102664. 16 indexed citations
12.
Yin, Xiaolin, Minran Zhou, Yue Fu, et al.. (2019). Histone demethylase RBP2 mediates the blast crisis of chronic myeloid leukemia through an RBP2/PTEN/BCR-ABL cascade. Cellular Signalling. 63. 109360–109360. 11 indexed citations
13.
Huang, Tao, Yue Fu, Siqi Wang, et al.. (2019). miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation. Biomedicine & Pharmacotherapy. 119. 109413–109413. 12 indexed citations
14.
Fu, Yue, Ya‐Ling Yang, Xiaoming Wang, et al.. (2018). The histone demethylase PHF8 promotes adult acute lymphoblastic leukemia through interaction with the MEK/ERK signaling pathway. Biochemical and Biophysical Research Communications. 496(3). 981–987. 16 indexed citations
16.
Wang, Xiaoming, Minran Zhou, Yue Fu, et al.. (2016). RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2. PLoS ONE. 11(3). e0152142–e0152142. 4 indexed citations
17.
Li, Lupeng, Lixiang Wang, Ping Song, et al.. (2014). Critical role of histone demethylase RBP2 in human gastric cancer angiogenesis. Molecular Cancer. 13(1). 81–81. 39 indexed citations
18.
Zhou, Minran, Jiping Zeng, Xiaoming Wang, et al.. (2014). Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia. Oncotarget. 6(2). 1249–1261. 34 indexed citations
19.
Zhou, Minran, Jiping Zeng, Xiaoming Wang, et al.. (2013). MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1. Journal of Translational Medicine. 11(1). 265–265. 29 indexed citations
20.
Zhang, Xiaolu, Jiping Zeng, Minran Zhou, et al.. (2012). The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia. Molecular Cancer. 11(1). 56–56. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026